Later, genetic studies have permitted the identification of new mutations in the GLI1 and GLI3 genes, probably associated with gains of function in breast and pancreatic cancer, as well as polymorphisms in GLI3 that may predispose to colorectal cancer [41,42,43]. Here, GLI3 is linked to pancreatic neoplasm.